Dexcom Inc. Files 2024 10-K
Ticker: DXCM · Form: 10-K · Filed: 2025-02-18T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, medical-devices
Related Tickers: DXCM
TL;DR
Dexcom filed its 2024 10-K. All systems go.
AI Summary
Dexcom Inc. filed its 2024 10-K on February 18, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in San Diego, CA, operates in the surgical and medical instruments sector. Key financial data and operational details for the fiscal year 2024 are presented in this comprehensive filing.
Why It Matters
This filing provides investors and the public with a detailed overview of Dexcom's financial performance and business operations for the 2024 fiscal year, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual report filing with no immediate red flags.
Key Numbers
- 2024 — Fiscal Year (The period covered by the 10-K filing.)
- 1231 — Fiscal Year End (Indicates the end date of the reporting period.)
- 000-51222 — SEC File Number (Unique identifier for Dexcom's SEC filings.)
Key Players & Entities
- Dexcom Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-18 (date) — Filing date
- San Diego, CA (location) — Company headquarters
- 3841 (industry_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
FAQ
What were Dexcom's total revenues for the fiscal year 2024?
The provided text does not contain specific revenue figures for fiscal year 2024.
What is Dexcom's primary business segment?
Dexcom Inc. is classified under Standard Industrial Classification 3841, which is Surgical & Medical Instruments & Apparatus.
When was Dexcom Inc. incorporated?
The state of incorporation for Dexcom Inc. is Delaware (DE).
What is the business address of Dexcom Inc.?
The business address is 6340 Sequence Drive, San Diego, CA 92121.
What is the SEC file number for Dexcom Inc.'s filings?
The SEC file number for Dexcom Inc. is 000-51222.
From the Filing
0001093557-25-000036.txt : 20250218 0001093557-25-000036.hdr.sgml : 20250218 20250214175237 ACCESSION NUMBER: 0001093557-25-000036 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 117 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250218 DATE AS OF CHANGE: 20250214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 25631453 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 10-K 1 dxcm-20241231.htm 10-K dxcm-20241231 false 2024 FY 0001093557 P3Y P4Y P1Y P1Y 0.0243476 0.006662 0.0061571 http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense P3Y iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure dxcm:purchaser utr:D dxcm:trading_day dxcm:extensionOption dxcm:segment dxcm:primary_market 0001093557 2024-01-01 2024-12-31 0001093557 2024-06-28 0001093557 2025-02-06 0001093557 2024-10-01 2024-12-31 0001093557 2024-12-31 0001093557 2023-12-31 0001093557 2023-01-01 2023-12-31 0001093557 2022-01-01 2022-12-31 0001093557 us-gaap:CommonStockMember 2021-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001093557 us-gaap:RetainedEarningsMember 2021-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2021-12-31 0001093557 2021-12-31 0001093557 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001093557 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001093557 us-gaap:CommonStockMember 2022-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001093557 us-gaap:RetainedEarningsMember 2022-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2022-12-31 0001093557 2022-12-31 0001093557 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001093557 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001093557 us-gaap:CommonStockMember 2023-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001093557 us-gaap:RetainedEarningsMember 2023-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2023-12-31 0001093557 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0001093557 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001093557 us-gaap:CommonStockMember 2024-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001093557 us-gaap:RetainedEarningsMember 2024-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2024-12-31 0001093557 dxcm:CustomerAMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNe